These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 20527538)
1. Experimental and theoretical dosimetry of a new polymer encapsulated iodine-125 source--SmartSeed: dosimetric impact of fluorescence x rays. Abboud F; Hollows M; Scalliet P; Vynckier S Med Phys; 2010 May; 37(5):2054-62. PubMed ID: 20527538 [TBL] [Abstract][Full Text] [Related]
2. An experimental palladium-103 seed (OptiSeedexp) in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect. Abboud F; Scalliet P; Vynckier S Med Phys; 2008 Dec; 35(12):5841-50. PubMed ID: 19175140 [TBL] [Abstract][Full Text] [Related]
3. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source. Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485 [TBL] [Abstract][Full Text] [Related]
4. Thermoluminescent dosimetry of the Symmetra 125I model I25.S06 interstitial brachytherapy seed. Patel NS; Chiu-Tsao ST; Williamson JF; Fan P; Duckworth T; Shasha D; Harrison LB Med Phys; 2001 Aug; 28(8):1761-9. PubMed ID: 11548947 [TBL] [Abstract][Full Text] [Related]
5. Dosimetric characteristics of the Pharma Seed model BT-125-I source. Popescu CC; Wise J; Sowards K; Meigooni AS; Ibbott GS Med Phys; 2000 Sep; 27(9):2174-81. PubMed ID: 11011748 [TBL] [Abstract][Full Text] [Related]
6. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data. Aryal P; Molloy JA; Rivard MJ Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593 [TBL] [Abstract][Full Text] [Related]
7. Polymer gel dosimetry for the TG-43 dosimetric characterization of a new 125I interstitial brachytherapy seed. Papagiannis P; Pantelis E; Georgiou E; Karaiskos P; Angelopoulos A; Sakelliou L; Stiliaris S; Baltas D; Seimenis I Phys Med Biol; 2006 Apr; 51(8):2101-11. PubMed ID: 16585848 [TBL] [Abstract][Full Text] [Related]
8. Experimental determination of the Task Group-43 dosimetric parameters of the new I25.S17plus (125)I brachytherapy source. Moutsatsos A; Pantelis E; Papagiannis P; Baltas D Brachytherapy; 2014; 13(6):618-26. PubMed ID: 25108795 [TBL] [Abstract][Full Text] [Related]
9. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed. Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418 [TBL] [Abstract][Full Text] [Related]
10. Investigation of the dosimetric parameters of Ait-Mlouk L; Khalis M; Asnaoui H; Ouabi H; Elboukhari S Appl Radiat Isot; 2022 Aug; 186():110294. PubMed ID: 35660985 [TBL] [Abstract][Full Text] [Related]
11. Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the (125)I I-Seed AgX100 source model. Mourtada F; Mikell J; Ibbott G Brachytherapy; 2012; 11(3):237-44. PubMed ID: 21816684 [TBL] [Abstract][Full Text] [Related]
12. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264 [TBL] [Abstract][Full Text] [Related]
13. Dosimetric characteristics of the InterSource103 palladium brachytherapy source. Meigooni AS; Sowards K; Soldano M Med Phys; 2000 May; 27(5):1093-100. PubMed ID: 10841414 [TBL] [Abstract][Full Text] [Related]
14. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism. Ho Than MT; Munro Iii JJ; Medich DC J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489 [TBL] [Abstract][Full Text] [Related]
15. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system. Medich DC; Munro JJ Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972 [TBL] [Abstract][Full Text] [Related]
16. The use of new GAFCHROMIC EBT film for 125I seed dosimetry in Solid Water phantom. Chiu-Tsao ST; Medich D; Munro J Med Phys; 2008 Aug; 35(8):3787-99. PubMed ID: 18777938 [TBL] [Abstract][Full Text] [Related]
17. Monte Carlo-aided dosimetry of the new Bebig IsoSeed 103Pd interstitial brachytherapy seed. Daskalov GM; Williamson JF Med Phys; 2001 Oct; 28(10):2154-61. PubMed ID: 11695778 [TBL] [Abstract][Full Text] [Related]
18. Monte Carlo and experimental dosimetry of an 1251 brachytherapy seed. Dolan J; Lia Z; Williamson JF Med Phys; 2006 Dec; 33(12):4675-84. PubMed ID: 17278820 [TBL] [Abstract][Full Text] [Related]
19. Dosimetric study of a new polymer encapsulated palladium-103 seed. Bernard S; Vynckier S Phys Med Biol; 2005 Apr; 50(7):1493-504. PubMed ID: 15798339 [TBL] [Abstract][Full Text] [Related]
20. Dosimetric characteristics of a new 125I brachytherapy source. Gearheart DM; Drogin A; Sowards K; Meigooni AS; Ibbott GS Med Phys; 2000 Oct; 27(10):2278-85. PubMed ID: 11099194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]